PRA International's Oncology Experts Host Innovative Panels at ASCO

Interactive Round-Table Sessions Address Critical Issues

RALEIGH, N.C., May 26 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, will host five interactive oncology round-table sessions at ASCO's annual meeting in Chicago 4-8 June 2010.

Conference attendees can join PRA's leading oncology experts in our conference room (located within booth 22085) to discuss solutions to many of the current issues and challenges facing oncology product development. Our interactive round tables will offer a forum for members of the oncology community to explore crucial topics and exchange ideas with proven industry leaders. These round-table sessions will review:

  • The minimum number of patients required for oncology trials.
  • Successes and lessons learned in emerging markets.
  • Evidence-based approaches in oncology studies.
  • The next generation of oncology drug development.
  • New developments in lung cancer and their impact on trial designs.

PRA will also exhibit at booth 22085, where attendees can further explore our extensive oncology and hematology experience as well as our company's other services and programs.

A recognized leader in oncology and hematology, PRA has more than 20 years of study experience that encompasses 40 indications within this therapeutic area, with our services contributing to the approval of many leading and innovative cancer drugs. PRA's depth in oncology and hematology is demonstrated by the 70% of our clinical staff who have experience in this therapeutic area.

For more information about our ASCO round-table sessions, navigate to www.praintl.com and click on "Events."  To reserve your seat, send email to [email protected].

About PRA International

PRA International conducts clinical trials in more than 75 countries across 6 continents and provides services through all phases of clinical development. PRA performs studies in all therapeutic areas, with specialization in Oncology, Neurosciences, Respiratory/Allergy, Cardiovascular and Infectious Diseases. In the last five years, PRA has supported over 2,700 clinical trials through its 37 global offices.

PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on-time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.

To learn more about PRA International, please visit www.PRAinternational.com, email [email protected] or call our Global Headquarters at +1 (919) 786-8200.

SOURCE PRA International

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.